Literature DB >> 9222274

Managing the late complications of Parkinson's disease.

C H Waters1.   

Abstract

Most patients with Parkinson's disease (PD) receiving chronic levodopa therapy eventually manifest one or more motor response complications, including "wearing-off" phenomena and "on-off" phenomena. Additionally, as the disease progresses, motor, neurologic, and neuropsychiatric complications increase and may include freezing spells, falls, dementia, depression, and psychosis. The management of patients with advanced PD presents a special clinical challenge because patients may experience an enhanced sensitivity to small changes in plasma levodopa levels and because they may suffer adverse reactions to antiparkinsonian drugs. Management of advanced PD is directed toward decreasing the dose of the offending drug while raising the dose of an alternative drug, with the goal of maintaining symptom control. In this article, the spectrum of late complications experienced by patients with advanced PD and their management are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9222274     DOI: 10.1212/wnl.49.1_suppl_1.s49

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 2.  Does levodopa accelerate Parkinson's disease?

Authors:  T Simuni; M B Stern
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

3.  Shortness of breath, a 'wearing-off' symptom in Parkinson's disease.

Authors:  Waqas Khan; Sughra Naz; Abdul Qayyum Rana
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

4.  Treatment of advanced Parkinson's disease.

Authors:  Sara Varanese; Zoe Birnbaum; Roger Rossi; Alessandro Di Rocco
Journal:  Parkinsons Dis       Date:  2011-02-07

5.  Clinical aspects of palliative care in advanced Parkinson's disease.

Authors:  Johan Lokk; Ahmad Delbari
Journal:  BMC Palliat Care       Date:  2012-10-25       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.